Race and alzheimer disease biomarkers: a neglected race

dc.contributor.author Lleó, Alberto
dc.contributor.author Suárez-Calvet, Marc
dc.date.accessioned 2021-07-07T07:09:49Z
dc.date.available 2021-07-07T07:09:49Z
dc.date.issued 2021
dc.format.mimetype application/pdf
dc.identifier.citation Lleó A, Suárez-Calvet M. Race and alzheimer disease biomarkers: a neglected race. Neurol Genet. 2021;7(2):e574. DOI: 10.1212/NXG.0000000000000574
dc.identifier.doi http://dx.doi.org/10.1212/NXG.0000000000000574
dc.identifier.issn 2376-7839
dc.identifier.uri http://hdl.handle.net/10230/48102
dc.language.iso eng
dc.publisher Wolters Kluwer (LWW)
dc.relation.ispartof Neurol Genet. 2021;7(2):e574
dc.rights © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.title Race and alzheimer disease biomarkers: a neglected race
dc.type info:eu-repo/semantics/article
dc.type.version info:eu-repo/semantics/publishedVersion

Col·leccions